Refractory subacute cutaneous lupus erythematosus treated with rituximab

Saved in:
Bibliographic Details
Published in:Actas dermo-sifiliográficas (English ed.) 2012-07, Vol.103 (6), p.555
Main Authors: Cieza-Díaz, D E, Avilés-Izquierdo, J A, Ceballos-Rodríguez, C, Suárez-Fernández, R
Format: Article
Language:Spanish
Subjects:
Adult
Antibodies, Monoclonal, Murine-Derived - therapeutic use
Anticonvulsants - therapeutic use
Antimalarials - therapeutic use
Drug Resistance
Drug Therapy, Combination
Epilepsy - complications
Epilepsy - drug therapy
Etanercept
Female
Humans
Immunoglobulin G - therapeutic use
Immunoglobulins, Intravenous - therapeutic use
Immunosuppressive Agents - administration & dosage
Immunosuppressive Agents - adverse effects
Immunosuppressive Agents - therapeutic use
Lupus Erythematosus, Cutaneous - drug therapy
Lupus Erythematosus, Systemic - complications
Middle Aged
Prednisone - therapeutic use
Receptors, Tumor Necrosis Factor - therapeutic use
Remission Induction
Rituximab
Thalidomide - therapeutic use
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1578-2190
DOI:10.1016/j.ad.2011.10.013